These findings indicate that upregulated tumor NOS2 and COX2 expression at the single cell level is predictive of poor survival and is consistent with the previous NOS2 and COX2 IHC scoring, which showed strong predictive power of tumor NOS2 and COX2 expression in ER− breast cancer (2, 4, 17). The gene discussed is NOS2; the disease is breast carcinoma.